JUBLPHARMA Q1 FY27 results at a glance
JUBILANT PHARMOVA LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹2,221 cr |
|---|
| Revenue YoY | +18.2% |
|---|
| Operating profit | ₹121 cr |
|---|
| Operating margin | 5.4% |
|---|
| Net profit | ₹56.5 cr |
|---|
| Net profit YoY | -45.1% |
|---|
| Net profit QoQ | -52.7% |
|---|
| Net margin | 2.5% |
|---|
| Basic EPS | ₹3.57 |
|---|
| TTM revenue | ₹8,488 cr |
|---|
| TTM net profit | ₹335 cr |
|---|
| TTM net margin | 3.9% |
|---|
JUBLPHARMA Q1 FY27 results: what the numbers say
JUBILANT PHARMOVA LTD (JUBLPHARMA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹2,221 cr and a net profit of ₹56.5 cr, translating into earnings per share of ₹3.57.
Compared with the same quarter a year earlier, revenue grew by +18.2% and net profit declined strongly by -45.1%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹121 cr, an operating margin of 5.4% versus 10.2% a year ago — a contraction of 4.8 percentage points.
JUBLPHARMA quarter-wise results table
Revenue
₹2,221 cr
+18.2% YoY
Net profit
₹56.5 cr
-45.1% YoY
Operating profit
₹121 cr
-37.0% YoY
JUBILANT PHARMOVA LTD (JUBLPHARMA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹2,221 cr | ₹121 cr | ₹56.5 cr | 5.4% | 2.5% | ₹3.57 | -45.1% | -52.7% |
| Q4 FY262026-03-31 | ₹2,272 cr | ₹223 cr | ₹119 cr | 9.8% | 5.3% | ₹7.55 | -22.3% | +113.6% |
| Q3 FY262025-12-31 | ₹2,116 cr | ₹169 cr | ₹55.9 cr | 8.0% | 2.6% | ₹3.52 | — | -45.7% |
| Q1 FY262025-06-30 | ₹1,879 cr | ₹192 cr | ₹103 cr | 10.2% | 5.5% | ₹6.49 | — | -33.0% |
| Q4 FY252025-03-31 | ₹1,916 cr | ₹250 cr | ₹154 cr | 13.1% | 8.0% | ₹9.71 | — | — |
| TTM (last 4 quarters) | ₹8,488 cr | ₹704 cr | ₹335 cr | 8.3% | 3.9% | ₹21.13 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
JUBLPHARMA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
JUBILANT PHARMOVA LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹2,221 cr | ₹2,272 cr | ₹2,116 cr | ₹1,879 cr | ₹1,916 cr |
|---|
| Total expenses | ₹2,100 cr | ₹2,050 cr | ₹1,947 cr | ₹1,687 cr | ₹1,666 cr |
|---|
| Gross profit | ₹1,472 cr | ₹1,559 cr | ₹1,400 cr | ₹1,261 cr | ₹1,290 cr |
|---|
| Operating profit (EBIT) | ₹121 cr | ₹223 cr | ₹169 cr | ₹192 cr | ₹250 cr |
|---|
| Operating margin | 5.4% | 9.8% | 8.0% | 10.2% | 13.1% |
|---|
| Interest cost | ₹54.2 cr | ₹56.5 cr | ₹56.1 cr | ₹49 cr | ₹52.7 cr |
|---|
| Profit before tax | ₹86.4 cr | ₹176 cr | ₹93.4 cr | ₹154 cr | ₹206 cr |
|---|
| Tax expense | ₹30 cr | ₹56.7 cr | ₹37.6 cr | ₹51.9 cr | ₹54.7 cr |
|---|
| Effective tax rate | 34.7% | 32.2% | 40.3% | 33.6% | 26.6% |
|---|
| Net profit (PAT) | ₹56.5 cr | ₹119 cr | ₹55.9 cr | ₹103 cr | ₹154 cr |
|---|
| Net profit margin | 2.5% | 5.3% | 2.6% | 5.5% | 8.0% |
|---|
| Basic EPS | ₹3.57 | ₹7.55 | ₹3.52 | ₹6.49 | ₹9.71 |
|---|
| Diluted EPS | ₹3.56 | ₹7.52 | ₹3.52 | ₹6.47 | ₹9.68 |
|---|
JUBLPHARMA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +18.2% | +18.6% | — | — | — |
|---|
| Revenue QoQ | -2.2% | +7.4% | +12.6% | -1.9% | — |
|---|
| Operating profit YoY | -37.0% | -11.1% | — | — | — |
|---|
| Operating profit QoQ | -45.8% | +31.8% | -11.9% | -23.5% | — |
|---|
| Net profit YoY | -45.1% | -22.3% | — | — | — |
|---|
| Net profit QoQ | -52.7% | +113.6% | -45.7% | -33.0% | — |
|---|
| EPS YoY | -45.0% | -22.2% | — | — | — |
|---|
| EPS QoQ | -52.7% | +114.5% | -45.8% | -33.2% | — |
|---|
JUBLPHARMA annual results history
Full-year performance for JUBILANT PHARMOVA LTD, useful for reading each quarter in context.
JUBILANT PHARMOVA LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹8,225 cr | ₹7,192 cr | ₹6,645 cr | ₹6,219 cr |
|---|
| Total expenses | ₹7,406 cr | ₹6,385 cr | ₹6,122 cr | ₹5,989 cr |
|---|
| Gross profit | ₹5,234 cr | ₹4,581 cr | ₹4,223 cr | ₹3,997 cr |
|---|
| Operating profit (EBIT) | ₹819 cr | ₹807 cr | ₹523 cr | ₹230 cr |
|---|
| Operating margin | 10.0% | 11.2% | 7.9% | 3.7% |
|---|
| Interest cost | ₹201 cr | ₹221 cr | ₹256 cr | ₹169 cr |
|---|
| Profit before tax | ₹614 cr | ₹981 cr | ₹171 cr | ₹27.8 cr |
|---|
| Tax expense | ₹217 cr | ₹144 cr | ₹97.8 cr | ₹92.7 cr |
|---|
| Effective tax rate | 35.3% | 14.7% | 57.4% | 333.5% |
|---|
| Net profit (PAT) | ₹399 cr | ₹839 cr | ₹77.1 cr | -₹61 cr |
|---|
| Net profit margin | 4.8% | 11.7% | 1.2% | -1.0% |
|---|
| Basic EPS | ₹25.15 | ₹52.99 | ₹4.87 | ₹-3.83 |
|---|
| Diluted EPS | ₹25.08 | ₹52.85 | ₹4.86 | ₹-3.83 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹2,221 cr against ₹1,879 cr in Q1 FY26, and ₹2,272 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -2.2%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹2,100 cr, or 94.6% of revenue, with operating profit declined -37.0% year on year.
Margins, tax and profitability
Net profit of ₹56.5 cr works out to a net margin of 2.5% compared with 5.5% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, JUBILANT PHARMOVA LTD reported profit before tax of ₹86.4 cr, a tax charge of ₹30 cr (effective rate 34.7%), interest cost of ₹54.2 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹119 cr in Q4 FY26 to ₹56.5 cr in Q1 FY27, a change of -52.7%.
Trailing twelve months and annual context
Across the trailing four quarters JUBILANT PHARMOVA LTD has generated revenue of ₹8,488 cr and net profit of ₹335 cr, a trailing net margin of 3.9%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹8,225 cr with net profit of ₹399 cr and EPS of ₹25.15, versus the prior year where revenue grew +14.4% and profit declined -52.5%.
What to watch in the next JUBLPHARMA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
JUBILANT PHARMOVA LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
JUBLPHARMA results coverage
No results report published for JUBLPHARMA yet — our desk covers each quarter within minutes of the filing.
More on JUBLPHARMA
JUBLPHARMA quarterly results FAQs
What were JUBILANT PHARMOVA LTD (JUBLPHARMA) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), JUBILANT PHARMOVA LTD reported revenue of ₹2,221 cr and net profit of ₹56.5 cr, a change of -45.1% year on year on +18.2% revenue growth. EPS stood at ₹3.57.
What is JUBLPHARMA profit margin in Q1 FY27?
JUBILANT PHARMOVA LTD posted a net profit margin of 2.5% and an operating margin of 5.4% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹8,488 cr and net profit ₹335 cr.
Did JUBLPHARMA results beat the previous quarter?
JUBILANT PHARMOVA LTD net profit changed -52.7% quarter on quarter, from ₹119 cr in Q4 FY26 to ₹56.5 cr in Q1 FY27.
When are JUBILANT PHARMOVA LTD (JUBLPHARMA) quarterly results?
JUBILANT PHARMOVA LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see JUBLPHARMA latest quarterly results?
Results coverage for JUBLPHARMA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the JUBLPHARMA stock page.
What is JUBILANT PHARMOVA LTD annual revenue and profit?
For FY26, JUBILANT PHARMOVA LTD reported full-year revenue of ₹8,225 cr and net profit of ₹399 cr, with EPS of ₹25.15.
How many quarterly results has JUBLPHARMA declared recently?
Past results dates for JUBLPHARMA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
